Insider · CIK 0002043395
Pierre Sargis Sayad
Files at FENC (FENNEC PHARMACEUTICALS INC.). First filing Aug 31, 2026, latest Aug 31, 2026.
In brief
Pierre Sargis Sayad files SEC Form 4 as officer at FENC (FENNEC PHARMACEUTICALS INC.). Since Aug 31, 2026, Pierre Sargis Sayad has reported 0 open-market buys worth $0 and 1 open-market sell worth $146k, the latest filed on Aug 31, 2026.
A track record needs three past buys with six months of prices behind them; Pierre Sargis Sayad has 0, so none is measured yet.
The newest scored trade: sold $146k of FENC on Aug 31, 2026, filed Aug 31, 2026, scored 61 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $146k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FENC: FENNEC PHARMACEUTICALS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | FENNEC PHARMACEUTICALS INC. | $146k 12,000 shares | -56% | +114% from low-3% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 12,000 0.03% of outstanding | $146k | Aug 31, 2026 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 9,687 | 12 d ago |
| Aug 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 21,519 | 43 d ago |
| Aug 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares | -12,000 | $12.18 | $146k | 9,519 | 43 d ago |
| Jul 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 21,351 | Aug 3, 2026 |
| Jun 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 21,183 | Jul 1, 2026 |
| May 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +168 | $0.00 | $0 | 21,015 | Jun 1, 2026 |
| Apr 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares | +168 | $0.00 | $0 | 20,847 | May 1, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares | +18,456 | $0.00 | $0 | 18,456 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +171 | $0.00 | $0 | 18,627 | Apr 2, 2026 |
| Mar 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +2,052 | $0.00 | $0 | 20,679 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +120,000 | $5.77 | $692k | 270,000 | Apr 2, 2026 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Restricted Share Unitderivative | +10,000 | $0.00 | $0 | 160,000 | Apr 3, 2025 |
| Nov 13, 2024 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +150,000 | $4.23 | $635k | 150,000 | Nov 13, 2024 |
Questions about Pierre Sargis Sayad
Answered from the filings on this page, as of the latest one.
Is Pierre Sargis Sayad buying or selling?
In the last 12 months Pierre Sargis Sayad reported 0 open-market buys worth $0 and 1 open-market sell worth $146k on SEC Form 4; the latest was sold $146k of FENC on Aug 31, 2026. Grants, option exercises and tax withholding are not counted.
How did Pierre Sargis Sayad's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pierre Sargis Sayad has 0.
Where does Pierre Sargis Sayad file Form 4?
Pierre Sargis Sayad has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.